If you need more lookups,
subscriptions start at $34 USD/month.
Apurva Saraf Location
Bridgewater, NJ, US
Apurva Saraf Work
President and CEO @ (July 2020 - Present)
Senior Vice President - Global Strategy and Corporate Development @ (January 2020 - July 2020)
Vice President, Global Strategy and Corporate Development @ (September 2012 - December 2019)
Co-Founder @ (August 2013 - May 2018)
Associate Director - Business Development @ (January 2009 - January 2012)
Associate Director @ (January 2008 - January 2009)
Associate Analyst, Equity Research @ (January 2006 - January 2008)
Associate Analyst @ (January 2005 - January 2006)
Senior Associate @ (January 2003 - January 2005)
Apurva Saraf Education
Baruch College
Master of Business Administration (Finance)
2001-2003
Sydhenam College
Master of Commerce (Finance)
2000-2001
Narsee Monjee College
Bachelor of Commerce (Economics, Accounting)
Jamnabai Narsee School
Apurva Saraf Skills
Corporate Development
Global Business Development
In-Licensing
Generics
Pharmaceutical Industry
Valuation
Portfolio Management
Private Equity
Corporate Finance
Due Diligence
Investments
Biotechnology
Business Strategy
Competitive Analysis
Equity Research
Financial Analysis
Financial Modeling
Generic Programming
Mergers
Regulatory Affairs
Technology Transfer
Leadership
Marketing
In Licensing
Microsoft Office
Strategic Planning
Entrepreneurship
Business Development
Research
SQL
Business Analysis
Apurva Saraf Summary
Apurva Saraf, based in Bridgewater, NJ, US, is currently a President and CEO at Cosette Pharmaceuticals, Inc.. Apurva Saraf brings experience from previous roles at Amneal Pharmaceuticals, Gemini Laboratories, LLC and Ranbaxy. Apurva Saraf holds a 2001 - 2003 Master of Business Administration in Finance @ Baruch College. With a robust skill set that includes Corporate Development, Global Business Development, In-Licensing, Generics, Pharmaceutical Industry and more. Apurva Saraf has 3 emails and 1 mobile phone numbers on RocketReach.
Looking for a different Apurva Saraf?
Find contact details for 700 million professionals.